Today: The Natus Medical Inc. (BABY) to Release Earnings on Wednesday

The Natus Medical Inc. (BABY) to Release Earnings on Wednesday

Natus Medical Inc. (NASDAQ:BABY) is set to announce its Q316 earnings results on Wednesday, October 19th.

Shares of Natus Medical Inc. (NASDAQ:BABY) opened at 40.15 on Tuesday. Natus Medical Inc. has a 12-month low of $29.54 and a 12-month high of $51.05. The firm has a market cap of $1.30 billion, a P/E ratio of 34.61 and a beta of 0.78. The firm has a 50-day moving average price of $41.05 and a 200-day moving average price of $37.00.

BABY has been the subject of a number of research analyst reports. Raymond James Financial Inc. upgraded Natus Medical from a “market perform” rating to an “outperform” rating and set a $46.00 price target for the company in a report on Tuesday, September 13th. Benchmark Co. initiated coverage on Natus Medical in a report on Tuesday, October 4th. They issued a “buy” rating and a $55.00 price target for the company. Finally, Zacks Investment Research downgraded Natus Medical from a “buy” rating to a “hold” rating in a report on Wednesday, September 28th.

In related news, insider James B. Hawkins acquired 10,000 shares of the stock in a transaction that occurred on Wednesday, September 28th. The stock was purchased at an average cost of $38.48 per share, for a total transaction of $384,800.00. Following the purchase, the insider now directly owns 459,725 shares in the company, valued at $17,690,218. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 4.80% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of BABY. BlackRock Inc. increased its position in shares of Natus Medical by 36.0% in the second quarter. BlackRock Inc. now owns 3,096 shares of the company’s stock worth $117,000 after buying an additional 820 shares during the last quarter. Invictus RG increased its position in shares of Natus Medical by 8.7% in the second quarter. Invictus RG now owns 4,200 shares of the company’s stock worth $159,000 after buying an additional 336 shares during the last quarter. Trexquant Investment LP bought a new position in shares of Natus Medical during the second quarter worth approximately $302,000. Clinton Group Inc. increased its position in shares of Natus Medical by 0.7% in the second quarter. Clinton Group Inc. now owns 8,614 shares of the company’s stock worth $326,000 after buying an additional 64 shares during the last quarter. Finally, Raymond James & Associates increased its position in shares of Natus Medical by 2.5% in the second quarter. Raymond James & Associates now owns 14,900 shares of the company’s stock worth $563,000 after buying an additional 367 shares during the last quarter. Hedge funds and other institutional investors own 88.00% of the company’s stock.

Natus Medical Company Profile

Related posts

Leave a Comment